In findings that could have implications for autoimmune disorders and drug-resistant bacterial infections, researchers at the University of California, San Diego (UCSD) School of Medicine have ident
A team of researchers from Lund University in Sweden have found that exposure to a class of environmental pollutants can change the ratio of sperm carrying male and female chromosomes.A baby's sex i
Dementia is now the latest scare factor to be added to an ever growing list of threats which so far includes diabetes, heart disease and stroke, which obese people are apparently more prone to.According to research in the US, obesity, particula
By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develo
The chemotherapy drug motexafin gadolinium (brand name: Xcytrin, manufactured by Pharmacyclics, Inc.) works to thwart cancer cells by disrupting key enzymes involved in cellular metabolism, according to a team of researchers led by Joseph Hacia, Ph.D.,
Blocking the COX-1 enzyme - not COX-2 - might lead to a way to prevent and treat the most common and fatal form of ovarian cancer, researchers at Vanderbilt University Medical Center reported th
Research conducted in monkeys at the Oregon National Primate Research Center, Oregon Health & Science University, suggests high doses of vitamin C may have potential to counteract some negative impac
A computerized tool to help emergency room physicians determine whether a patient is having a heart attack may not work as well among some racial and ethnic groups, according to research of almost 12,000 patients at nine medical centers. "It's
Age-related macular degeneration, the leading cause of blindness in the elderly, occurs when a common inherited gene variation is triggered, possibly by an infection, according to a new study led by researchers at
Children exposed to cocaine before birth show subtle but discernible differences in their ability to plan and problem-solve once they reach school age, University of Florida researchers report.Sti
Date: Tuesday, 12-Sep-2006
Magnetic resonance imaging (MRI) with an approved contrast agent may provide a practical way of monitoring the survival of transplanted pancreatic islets.In the September issue of the journal Diabetes, researchers from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) report successfully tracking over time the fate of islets transplanted into mice using a protocol currently being tested in human patients.
"Clinical trials and animal studies show that there is a significant loss of islets following transplantation due to many factors, not just rejection," says Anna Moore, PhD, of the MGH Martinos Center, who led the study. "Currently there is no direct way to follow the causes behind this loss and how it proceeds over time. Monitoring islet survival by noninvasive imaging could give us the ability to detect and measure rates of islet loss under a variety of conditions, which could help develop procedures leading to better therapeutic outcomes."
Pancreatic islet transplants are being investigated as a way to treat or cure patients with type 1 diabetes, in which the insulin-producing islets are attacked by the body's immune system. In an effort to replace destroyed islets and restore normal insulin production and glucose metabolism, several methods of islet transplantation have been developed and tested. One of the most promising - called the Edmonton Protocol, since it was developed at the University of Alberta - is currently the subject of a multicenter clinical trial. In a 2005 report, the Edmonton group noted that, while islet survival is improving, problems continue to exist both with immune rejection and with the initial post-transplantation engraftment of islets. Even in animal studies involving transplants from genetically identical donors, which should not produce immune rejection, as many as 60 percent of islets are lost in soon after the procedure.
In a previously published animal study, the MGH-Martinos group showed that MRI could detect transplanted islets that had been marked with experimental iron-containing nanoparticles. The current study utilized islets labeled with Feridex, an FDA-approved contrast agent, and procedures virtually identical to the Edmonton protocol, in which islets are infused into the recipient's liver. Labeled islets were transplanted into mice with a normal immune system and into mice with a severe genetic immune deficiency that would practically eliminate the rejection process. MR images of the animals' livers were taken seven times over the 14 days after the transplant procedure.
The results verified that that MRI could track the labeled islets over time and reveal how many were surviving. For both groups of mice, the number of islets began to drop immediately after transplantation and reached a plateau at 10 to 14 days. The researchers note that much of the early islet death probably was caused by factors other than rejection, such as damage during the transplant procedure. However, by day 10 the mice with normal immune systems showed a 20 percent greater loss of islets than did the immune-deficient animals - probably the result of rejection - and close examination verified significant immune cell activity in the normal mice.
"Since MRI can provide comprehensive information about the presence and position within the body of entities as small as islets and can be performed repeatedly without subjecting patients to radiation or any invasive procedure, we think it is the most appropriate imaging modality to monitor islet survival," says Moore. "Feridex is an approved imaging agent, so the next logical step could be human clinical trials, although it may be helpful to work on improving the imaging procedures with larger animals first." Moore is an assistant professor of Radiology at Harvard Medical School and director of the Molecular Imaging Laboratory at the Martinos Center.
http://www.mgh.harvard.edu/